Aurinia Pharmaceuticals Inc Stock Analysis
Technical stock analysis for 22 January 2019
Aurinia Pharmaceuticals Inc fell by -8.74% in the last day from $7.55 to $6.89 The price has risen in 6 of the last 10 days , but is still down by -2.55% for this period. Volume has increased in the last day by 4.20 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 5.42 million shares bought and sold for approximately $37.35 million.
Close price at the end of the last trading day (Tuesday, 22nd Jan 2019) of the AUPH stock was $6.89. This is 8.74% less than the trading day before Friday, 18th Jan 2019.
During day the stock fluctuated 11.70% from a day low at $6.75 to a day high of $7.54.
30 day high of the AUPH stock price was $7.85 and low was $5.50.
90 day high was $7.85 and low was $5.06.
52 week high for the Aurinia Pharmaceuticals Inc - $7.85 and low - $4.76.
Aurinia Pharmaceuticals Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 36.06% during the next 3 months and, with 90% probability hold a price between $8.34 and $10.58 at the end of this period.
There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Tuesday January 15, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Aurinia Pharmaceuticals Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $7.37. On a fall, the stock will find some support from the long-term average at approximately $6.47. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.
Relative Strength Index (RSI)
RSI14 is 51 and the stock is currently not being overbought or oversold
Support & Resistance
Aurinia Pharmaceuticals Inc finds support from accumulated volume at $6.84.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.79 between high and low, or 11.70%. For the last week, the stock has had a daily average volatility of 6.56%.
Our recommended stoploss: $6.47 (-6.12%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 4 days ago.)
Very Low Low Medium High Very High
Aurinia Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate.
|AUPH $6.89 $-0.66(-8.74%)|
AUPH is down $0.66 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AUPH based on the 1-3 month system that more than doubles the S&P 500.
Click here – the AUPH analysis is free »